title: [Pentoxifyllin in andrology (author's transl)].
abstract: Sperm investigations of 38 men with Oligo-Astheno-Teratozoospermia and inconspicuous gonadotropin-level treated with pentoxifyllin 3 x 400 mg/die for a period of 8 to 20 weeks have shown an increase in sperm-density of 10 Mio/ml. The increase was significant, but it concerns only 14 of the 38 patients while motility and morphology did not change.
mesh_terms: D006801:Humans; D007248:Infertility, Male / Q000188:drug therapy*; D008297:Male; D009845:Oligospermia / Q000188:drug therapy; D010431:Pentoxifylline / Q000627:therapeutic use*; D013076:Sperm Count; D013081:Sperm Motility / Q000187:drug effects; D013094:Spermatozoa / Q000002:abnormalities; D013739:Testosterone / Q000097:blood; D013805:Theobromine / Q000031:analogs & derivatives*
chemical_list: D013739:Testosterone; D013805:Theobromine; D010431:Pentoxifylline
vernacular_title: Pentoxifyllin in der andrologischen Therapie.